Timely Administration of IV Magnesium Sulfate in Patients With a Moderate Asthma Exacerbation

Recruiting now · Early Phase 1

Conditions studied: Asthma in Children, Asthma Attack

In brief

This study aims to identify whether early administration of magnesium sulfate in moderate asthma exacerbations can potentially avoid admission, decrease length of stay in the emergency department (ED), decrease length of stay (LOS) in the general hospital floor vs pediatric intensive care unit (PICU), and decrease the need for respiratory support.

Key facts

Study ID

NCT06137040

Run by

University of Oklahoma

People needed

100

Starts

2023-11-30

Expected to finish

2025-05-31

Last updated by the study team

2024-12-06

Who can join

Age: 5 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Ages 5-17 years old
• Presents to the ED with a respiratory score in the "Moderate" range (6
• Parent(s)/Caregiver(s) speak English

You may not qualify if…

• Patients with chronic medical conditions including chronic pulmonary disease (other than asthma), cerebral palsy, congenital heart disease, tracheostomy dependent, myasthenia gravis patients
• Patients who are pregnant
• Parent(s)/Caregiver(s) do not speak English

Where it is running

• Oklahoma Children's Hospital — Oklahoma City, Oklahoma, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.